Loading...

Ginkgo Bioworks Holdings, Inc. WT

DNA-WTNYSE
Healthcare
Biotechnology
$0.27
$-0.01(-2.76%)

Ginkgo Bioworks Holdings, Inc. WT (DNA-WT) Stock Overview

Explore Ginkgo Bioworks Holdings, Inc. WT’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.6/100

Key Financials

Market Cap18.7B
P/E Ratio-1.07
EPS (TTM)N/A
ROE-0.63%

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 Months$0.39
1 Year Target$0.02

DNA-WT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ginkgo Bioworks Holdings, Inc. WT (DNA-WT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.07 and a market capitalization of 18.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Revenue Growth
-9.71%
9.71%
Profit Growth
$-8.70
38.73%
EPS Growth
$-8.70
42.62%
Operating Margin
-198.27%
35.24%
ROE
-63.06%
38.73%
Dividend Yield
0.00%
Analyst Recommendations data is not available for DNA-WTAnalyst Recommendations details for DNA-WT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile data is not available for DNA-WTCompany Profile details for DNA-WT are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Frequently Asked Questions

;